Vaccine Against Children Diarrhea Wins FDA Approval
Posted on: Sunday, 5 February 2006, 09:00 CST
Vaccine against children diarrhea wins FDA approval
WASHINGTON, Feb. 3 (Xinhua) -- A vaccine protecting young children against a virus that causes severe diarrhea received the approval of the United States Food and Drug Administration (FDA) on Friday.
The new vaccine, Rotateq, is an oral liquid intended to prevent infection of a microbe called rotavirus that affects almost all children under 5.
Rotavirus kills about 500,000 children a year, mostly in developing countries, with severe diarrhea. The biggest risks are for children ages 6-24 months.
An earlier oral rotavirus vaccine, sold by Wyeth, was withdrawn from the market in 1999 after it was linked to intussusception, a rare, life-threatening blockage or twisting of the intestine.
Source: Xinhua News Agency - CEIS
Related Articles
- Vaccine shifts rotavirus transmission
- WHO Urges All Children Be Given Rotavirus Vaccine
- Common Children's Vaccine Recalled
- Partnership for Cleveland Children's Vaccinations Announced
- Lawmakers Approve Mercury Measure; Substance Largely Banned From Children's Vaccines
- Meningitis Among Targets of New Children's Vaccine
- New Vaccine Against Rotavirus Approved
- Merck Vaccine Reduces Rotavirus By 98%
- FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data From 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus Gastroenteritis
- Singapore Licenses New Vaccine Against Rotavirus Gastroenteritis in Children
 |
 |
User Comments (0)
RSS Feeds